RecruitingNCT06844643

The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study


Sponsor

China-Japan Friendship Hospital

Enrollment

2,250 participants

Start Date

Mar 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients aged 18 years or older
  • Diagnosis of axial spondyloarthritis (axSpA) according to the Assessment of Spondyloarthritis International Society (ASAS) classification criteria

Exclusion Criteria4

  • Presence of severe, unstable medical conditions that may interfere with the study assessments, including but not limited to:
  • End-stage renal disease (eGFR < 30 mL/min/1.73m²) Severe cardiovascular disease Active malignancy or malignancy requiring ongoing treatment
  • Current diagnosis of schizophrenia, other psychotic disorders, severe cognitive impairment, or epilepsy with recurrent uncontrolled seizures, which, in the opinion of the investigator, may impair the ability to provide informed consent or comply with follow-up visits.
  • Pregnant or lactating women

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

China-Japan Friendship Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06844643


Related Trials